DKBmed Radio

Share

cover art for 10/27/2021 - COVID-19 Vaccine and Treatment Hesitancy

10/27/2021

10/27/2021 - COVID-19 Vaccine and Treatment Hesitancy

Dr. Paul Auwaerter interviews Dr. David J. Malebranche about how we can address patient concerns and hesitancy with COVID-19 vaccines and treatments. Topics: *Addressing vaccine hesitancy with patients *Communicating the benefit of monoclonal antibodies *Storytelling as a means of addressing patient concerns

Post-test for CME/CE credit: https://covid19.dkbmed.com/multispecialty/10-27-21-episode/eval

Access our resource center, download webinar slides, and claim credit at https://covid19.dkbmed.com/multispecialty

Presenting faculty:

Paul G. Auwaerter, MD, MBA, FIDSA, Past President of the Infectious Diseases Society of America (IDSA), Professor of Medicine, Johns Hopkins University School of Medicine

David J. Malebranche, MD, MPH, Assistant Professor at the Division of General Medicine at Emory University’s School of Medicine

More Episodes

VIEW ALL

Is that MS Diagnosis Accurate?

Is it true that a significant number of patients being treated for MS may not actually have the disease? What are the red flags — warnings that something about the patient’s condition does not meet the accepted MS diagnostic criteria — that need to be investigated?Join us in thiseMultipleSclerosis Review podcast, as Neuroimmunologist Dr. Gabrielle Macaron from Saint Joseph University’s Hotel Dieu de France Hospital in Beirut, Lebanon, and the Cleveland Clinic’s Mellen Center for Multiple Sclerosis, explains strategies to reduce misdiagnosis of MS.Take ourpost-testto claim CME credits.To read a companion newsletterclick here.

Nonpharmacologic Symptom Management

In this Issue: Fatigue. Urinary dysfunction. Constipation. Spasticity and gait problems. Providing relief from these common MS symptoms often requires clinicians to go beyond the prescription pad to recommend nonpharmacologic treatments. What works? What doesn’t? What does the evidence say?Join us as Dr. W. Oliver Tobin from the Mayo Clinic discusses these questions in this eMultipleSclerosis Review podcast.Take ourpost-testto claim CME credits.To read a companion newsletterclick here.

COVID-19: The Morbidity/Mortality Risk

Are PLWH at higher risk for increased mortality from COVID-19 infection? How important is it for PWLH to get vaccinated and boosted? Is breakthrough COVID-19 infection more likely to occur among PLWH? What about “long COVID” (PASC)?Join Clinical Research Nurse Diane Kanjilal, manager of the Infectious Disease Clinical Research Unit at Massachusetts General Hospital, as we discuss these questions in thiseHIV Review podcast.Take ourpost-testto claim CME credits.To read a companion newsletterclick here.